Clinical progression on CDR‐SB©: Progression‐free time at each 0.5 unit level in dominantly inherited and sporadic Alzheimer's disease populations is a research paper published in Alzheimer s & Dementia (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U01 AG024904
U.S. Department of Defense
Grant: W81XWH‐12‐2‐0012
National Institute on Aging of the National Institutes of Health
Grant: R01AG053267
National Institute on Aging of the National Institutes of Health
Grant: U01AG042791-S1
Department of Defense
Grant: W81XWH-12-2-0012
National Institute on Aging of the National Institutes of Health
Grant: 1U01AG059798
NIA NIH HHS
Grant: R01 AG068319
National Institute on Aging of the National Institutes of Health
Grant: R01AG053267-S1
NIA NIH HHS
Grant: U01 AG042791
National Institute on Aging (NIA), the Alzheimer's Association
Grant: SG-20-690363-DIAN
NIA NIH HHS
Grant: U19 AG032438
Ministry of Health & Welfare and Ministry of Science and ICT, Republic of Korea
Grant: HI21C0066
NIA NIH HHS
Grant: P30 AG066530
NIA NIH HHS
Grant: R01 AG046179
NIA NIH HHS
Grant: R01 AG059798
National Institute on Aging of the National Institutes of Health
Grant: U01AG052564
NIA NIH HHS
Grant: U01 AG059798
National Institutes of Health
Grant: 1U01AG024904-01
Alzheimers Disease Neuroimaging Initiative
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 3P30AG066530-04S1
Alzheimer Disease Research Center
National Institutes of Health
Grant: 5R01AG055444-05
Alzheimer's Prevention Initiative ADAD Colombia Trial
National Institutes of Health
Grant: 1R01AG068319-01
DIAN-TU: Tau Next Generation Prevention Trial
National Institutes of Health
Grant: 5U01AG059798-03
DIAN-TU Primary Prevention Trial
National Institutes of Health
Grant: 3U01AG052564-02S2
Mapping the Human Connectome During Typical Aging
National Institutes of Health
Grant: 5U19AG032438-03
DIAN Genetics Core
National Institutes of Health
Grant: 5R01AG053267-02
DIAN-TU: Next Generation Prevention Trial
National Institutes of Health
Grant: 1R01AG054434-01A1
The delivery of essential fatty acids to the Brain in Alzheimer's disease
National Institutes of Health
Grant: 5R01AG063826-04
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
National Institutes of Health
Grant: 3U01AG042791-02S1
DOMINANTLY INHERITED ALZHEIMER NETWORK TRIAL: AN OPPORTUNITY TO PREVENT DEMENTIA
National Institutes of Health
Grant: 5R01AG046179-02
Dominantly Inherited Alzheimer's Network Trials Unit - Adaptive Prevention Trial
National Institutes of Health
Grant: 5R01AG051346-03
Novel Cognitive and Functional Measure for Alzheimer's Disease Prevention Trials
National Institutes of Health
Grant: 3R01AG062687-01S1
(-)-Phenserine inhibition of neuronal death in Alzheimer’s disease and developing brain-labeled plasma exosomes assays as biomarkers for a phenserine phase 1b ascending dose trial
National Institutes of Health
Grant: 3R01AG074983-02S1
Manufacturing of New Batch AV-1959D Drug Product and Placebo for Phase 1 Trial
Fields of Study
MeSH Terms
Keywords